Regulus Therapeutics Inc. (RGLS)
USD 1.51
(-6.79%)
USD 1.51
(-6.79%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -26.76 Million | -25.52 Million | -24.12 Million | -12.53 Million | -19.82 Million | -43.27 Million |
| Net Income | -30.03 Million | -28.32 Million | -27.8 Million | -15.73 Million | -18.59 Million | -48.7 Million |
| Depreciation & Amortization | 227 Thousand | 122 Thousand | 459 Thousand | 467 Thousand | 931 Thousand | 2.26 Million |
| Deferred income taxes | -29 Thousand | - | -662 Thousand | - | - | 148 Thousand |
| Stock-based compensation | 2.8 Million | 2.17 Million | 2.92 Million | 2.61 Million | 2.28 Million | 5.44 Million |
| Change in working capital | 257 Thousand | 550 Thousand | 914 Thousand | -41 Thousand | -6.58 Million | -3.17 Million |
| Other non-cash items | 13 Thousand | -52 Thousand | 46 Thousand | 154 Thousand | 2.13 Million | 756 Thousand |
| Investing Cash Flow | 14.49 Million | -15.12 Million | -251 Thousand | -11 Thousand | 74 Thousand | 46.51 Million |
| Investments in PPE | -613 Thousand | -361 Thousand | -251 Thousand | -11 Thousand | -244 Thousand | -22 Thousand |
| Acquisitions | 3000.00 | 14.75 Thousand | - | - | 318 Thousand | - |
| Investment purchases | -4.89 Million | -32.75 Million | - | - | - | - |
| Sales/Maturities of investments | 20 Million | 18 Million | - | - | - | 46.54 Million |
| Other Investing Activities | 15.1 Thousand | -14.75 Thousand | - | -11.00 | 295.00 | 46.54 Million |
| Financing Cash Flow | 11.81 Million | 4.49 Million | 53.73 Million | 9.51 Million | 39.93 Million | -2.83 Million |
| Debt repayment | -3.3 Million | - | -80 Thousand | -10.27 Million | -2.24 Million | -3.34 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 15.12 Million | 4.49 Million | 53.79 Million | 19.12 Million | 42.17 Million | 219 Thousand |
| Other Financing Activities | 10.69 Million | 4491.00 | 26 Thousand | 667 Thousand | 3000.00 | 293 Thousand |
| Accounts receivables | - | - | 503 Thousand | 638 Thousand | -1.11 Million | 347 Thousand |
| Accounts payables | 29 Thousand | -110 Thousand | -250 Thousand | -786 Thousand | -393 Thousand | -4.02 Million |
| Inventory | - | - | 304.00 | 610.00 | 270.00 | -606 Thousand |
| Other working capital | 228 Thousand | 660 Thousand | 660.69 Thousand | 106.39 Thousand | -5.07 Million | 1.11 Million |
| Cash at beginning of period | 24.29 Million | 60.44 Million | 31.08 Million | 34.12 Million | 13.93 Million | 13.51 Million |
| Cash at end of period | 23.82 Million | 24.29 Million | 60.44 Million | 31.08 Million | 34.12 Million | 13.93 Million |
| Capital Expenditure | -613 Thousand | -361 Thousand | -251 Thousand | -11 Thousand | -244 Thousand | -22 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -461 Thousand | -36.15 Million | 29.35 Million | -3.03 Million | 20.18 Million | 416 Thousand |
| Free Cash Flow | -27.38 Million | -25.88 Million | -24.37 Million | -12.54 Million | -20.06 Million | -43.29 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -11.03 Million | -8.46 Million | -30.03 Million | -8.06 Million | -7.82 Million | -7.01 Million |
| Depreciation & Amortization | 89 Thousand | 81 Thousand | 227 Thousand | 76 Thousand | 56 Thousand | 47 Thousand |
| Deferred income taxes | - | - | -29 Thousand | -1.58 Million | -51 Thousand | - |
| Stock-based compensation | 1.86 Million | 985 Thousand | 2.8 Million | 1.03 Million | 973 Thousand | 382 Thousand |
| Change in working capital | -1.85 Million | -1.5 Million | 257 Thousand | 846 Thousand | 537 Thousand | 282 Thousand |
| Other non-cash items | 1.15 Million | 1.1 Million | 13 Thousand | 1.56 Million | 32 Thousand | 50 Thousand |
| Investing Cash Flow | -83 Thousand | -78.54 Million | 14.49 Million | 4.93 Million | -5.44 Million | - |
| Investments in PPE | -83 Thousand | -229 Thousand | -613 Thousand | -71 Thousand | -541 Thousand | - |
| Acquisitions | - | - | 3000.00 | 3000.00 | - | - |
| Investment purchases | - | -78.31 Million | -4.89 Million | -5003.00 | -4.89 Million | - |
| Sales/Maturities of investments | - | - | 20 Million | 5 Million | - | - |
| Other Investing Activities | - | -78.31 Million | 15.1 Thousand | 5003.00 | -4899.00 | - |
| Financing Cash Flow | -744 Thousand | 93.1 Million | 11.81 Million | -873 Thousand | 287 Thousand | 13.2 Million |
| Debt repayment | -551 Thousand | -826 Thousand | -3.3 Million | -826 Thousand | -826 Thousand | -826 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -74 Thousand | - | - | -47.00 | - | - |
| Common Stock Issuance | -193 Thousand | 93.93 Million | 15.12 Million | -47 Thousand | 1.11 Million | 14.03 Million |
| Other Financing Activities | 1000.00 | 93.07 Million | 10.69 Million | 15.65 Million | 1113.00 | 13.2 Thousand |
| Accounts receivables | - | - | - | 2997.00 | 3.00 | 1000.00 |
| Accounts payables | 194 Thousand | 202 Thousand | 29 Thousand | -395 Thousand | 236 Thousand | -218 Thousand |
| Inventory | -172 Thousand | - | - | -2997.00 | -3.00 | -1000.00 |
| Other working capital | -2.05 Million | -1.7 Million | 228 Thousand | 1.24 Million | 300.99 Thousand | 500 Thousand |
| Cash at beginning of period | 29.64 Million | 23.82 Million | 24.29 Million | 25.89 Million | 37.32 Million | 30.37 Million |
| Cash at end of period | 17.18 Million | 29.64 Million | 23.82 Million | 23.82 Million | 25.89 Million | 37.32 Million |
| Capital Expenditure | -83 Thousand | -229 Thousand | -613 Thousand | -71 Thousand | -541 Thousand | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -12.46 Million | 5.81 Million | -461 Thousand | -2.06 Million | -11.43 Million | 6.95 Million |
| Free Cash Flow | -11.72 Million | -8.97 Million | -27.38 Million | -6.19 Million | -6.81 Million | -6.25 Million |
EXMGF
PANTH
4626
605286
6023
SII